Dichloromethane, ethanol, and boiling water extracts of the green seaweed Codium fragile, used as an herbal medicine and known as an invasive species over the world, were examined for anti-inflammatory, antipyretic, and analgesic activities in mice. The dichloromethane and ethanol extracts inhibited inflammatory symptoms of mouse ear edema and erythema by 74% or higher. The extracts also demonstrated inhibition of pyrexia, similar to that of acetyl salicylic acid. Eicosapentaenoic acid was isolated from the seaweed as the main active anti-inflammatory compound. These findings are consistent with various claims that the seaweed can be used as remedies for inflammation-related symptoms.
Introduction
Many studies have concentrated on the contribution of marine organisms, including seaweeds, to the search for new drugs from natural products. For drug development, selection of samples for biological activity is often based on assaying for active ingredients of organisms used in folk remedies [17] . A number of seaweed species are used as traditional medicines, foods and health-care in various regions of the world. A green seaweed Codium fragile (Suringar) Hariot as known as Chungkag, Nogkagche, or Chungkagche is used as a food additive, an anti-helminthic [10] , and to treat fever, especially in children, with fever accompanying pain, cough, and cold sweat, with no side effects [3] . It is also used as an herbal medicine in China to treat many urinary diseases, dropsy, and helminthiasis [19] . As material sources of herbal medicine in oriental countries, most of those medicinal effects of C. fragile are directly or indirectly related to anti-inflammatory action of the seaweed. Recently, Kang et al. [9] found that methanol extract of C. fragile regulated the expression and secretion of LPS-induced inflammatory mediators by inhibiting NF-κB activity. Annual production of C. fragile in 2009 was estimated at 553 tons (wet weight) by natural collection and 1,796 tons (wet weight) by aquaculture in Korea [14] . Annual growths of C. fragile, as an invasive species, are now found in temperate regions all over the world [20] . To evaluate the in vivo medicinal activity of C. fragile, abundant species with immense aquaculture potential, we measured anti-inflammatory activity of each extract of dichloromethane, ethanol, and boiling water against edema, erythema, local blood flow, hyperpyrexia, and algesthesia in mice. In an attempt to identify the main active anti-inflammatory compound from the seaweed, we found that eicosapentaenoic acid (EPA) showed inhibitory effects against inflammatory symptoms. By identifying large amounts of the anti-inflammatory EPA from C. fragile, we support claims that the seaweed has been used in health care and indigenous medicine as a remedy for inflammation-related symptoms. compounds. Ear edema (swelling) was measured 10 hr after the PMA application, using a spring-loaded micrometer (Mitutoyo Corp., Tokyo, Japan) [6] . Ear erythema was determined at 10 hr using digital photography, adjusted to balance white, and Photoshop 7.0 (Adobe, San Jose, CA, USA) to measure the magenta value [12] . To confirm the anti-inflammatory activity of the seaweed, local blood flow in the mouse ear was measured at 10 hr, using laser speckle flowgraphy (Inflameter LFG-1; SoftCare, Fukuoka, Japan) [15] .
Edema (AU), erythema (AU), and blood flow values (AU) were calculated, as (I10-I0)/I0, where I10 is the measurement at 10 hr after PMA application, and I0 is the measurement at 0 hr. Relative inhibition rate (%) was expressed as [(value of the control-value of the extract)/value of the control]×100. Indomethacin (0.3 mg per 10 μl ethanol per ear) was used as a standard.
Antipyretic and analgesic activities
Mice were divided into five groups of seven mice each.
The brewer's yeast-induced pyrexia model in female mice was used to test the antipyretic activity of seaweed extracts and fractions [18] . When the rectal temperature peaked after 24 hr, either 4 g of extracts in 10 ml of 5% Tween-80 or 10 ml of 5% Tween-80 (control) per kg body weight were administered orally, and the rectal temperature ( o C) was recorded after an additional 45 min, using an electric thermometer and probe, inserted 2 cm into the rectum. Relative antipyrexia (%) was expressed as [(value of the control-value of the extract)/value of the control]×100. Acetyl salicylic acid (150 mg/kg) was used as a standard. For analgesic activity, either extracts (1.5 g in 10 ml of 5% Tween-80 per kg) or control was administered intraperitoneally to mice by the tail-flick test [5] , and the tail-flick latency time (sec) was measured using the tail-flick unit (Ugo Basile, Varese, Italy) 1 hr later. Relative latency (%) was expressed as [(value of the extract-value of the control)/value of the control]×100. Acetyl salicylic acid (150 mg/kg) was used as a standard.
Acute toxicity test
Mice were fasted for 6 hr, with water provided ad libitum.
Extracts (5 g in 10 ml of 5% Tween-80 per kg) were administered orally to mice (n=5, each). The animals were observed for any abnormal behavior for 3 hr, and mortality was noted up to 2 weeks. A group of animals treated with the Tween-80 served as the control. (Shimadzu, Kyoto, Japan) equipped with a flame ionization detector, and compared to the spectral data from the Table 1 . Effect of Codium fragile extracts on anti-inflammatory, antipyretic, and analgesic activities against edema, erythema, and blood flow, respectively, in mice (Fig. 1) , and confirmed to be identical to data for authentic EPA.
Discussion
The green seaweed C. fragile is used as a food additive or herbal medicine in Korea and China. According to WHO [21] , herbal medicine is said to be toxic if the LD50 is lower than 5 g/kg body weight. From this assertion, it can be said that the C. fragile extracts are not toxic and can be safely used by humans at moderate doses, since no mortality at 5 g/kg body weight was recorded. In present study, dichloromethane and ethanol extracts of C. fragile demonstrated potent anti-inflammatory activities in PMA-induced mouse ear, and the main active constituent in the C. fragile extract was the polyunsaturated fatty acid EPA. In a previous work [11] , the EPA concentrations producing 50% inhibition (IC50) by topical application were 230, 462, and 236 μg per ear for edema, erythema, and blood flow, respectively. It showed almost half the anti-inflammatory activity of indomethacin. We also examined the amount of EPA in C. fragile thalli. Mature thalli of commercial product contained EPA with approximately 136 μg/g-dry powder.
Known for its anti-inflammatory effect, the compound in the seaweed may play as a competitive inhibitor of cyclooxygenase and/or lipoxygenase in an inflammation reaction, resulting in decreased production of prostaglandins and leukotrienes [8] . Ear inflammations induced by arachidonic acid and ultraviolet-B irradiation was also significantly suppressed in mice at a dose of 300 mg EPA per kg body weight per day for 2 weeks [2] . EPA inhibited UV-induced dermal fibroblasts [13] , leukocyte-endothelial interactions [16] , and inflammatory mediator release in blood and splenocytes of mice [7] . Supplementing with 50-100 µg/ml ω-3 PUFAs reduces the expression and activity of aggrecanases and inflammation-inducible cytokines and cyclooxygenase-2 [1] .
However, they had no effect on constitutively expressed cyclooxygenase-1. Thus, these findings for EPA from C. fragile reinforce the claims of the health-care industry and indigenous medicine that the seaweed can be used as a remedy for inflammation-related symptoms. In addition, the amount of EPA in C. fragile can be used as criteria for quality assessment of the seaweed products and for strain improvement.
초록：양식산 녹조류 청각(Codi um fragile) 추출물의 항염증, 해열 및 진통에 대한 생체활성 
